Mood Disorder Questionnaire

The Mood Disorder Questionnaire (MDQ) is a premier clinical screening instrument engineered to identify bipolar spectrum disorders, including Bipolar I, Bipolar II, and Bipolar Not Otherwise Specified (NOS). Originally developed by Dr. Robert Hirschfeld and a team of psychiatric researchers at the University of Texas Medical Branch, this self-report questionnaire addresses a massive bottleneck in healthcare and corporate wellness. In clinical and corporate settings alike, the delay between the onset of bipolar symptoms and an accurate medical diagnosis averages five to ten years. During this diagnostic gap, individuals are frequently misdiagnosed with unipolar depression and prescribed antidepressant monotherapy, an intervention that can severely destabilize the individual, accelerate rapid cycling, and lead to prolonged absenteeism or disability claims. From an occupational health and risk management perspective, the MDQ is structured to deliver rapid, reliable screening data within approximately five minutes. The tool is divided into three distinct operational sections. The primary section utilizes a 13-item binary checklist focused on lifetime manic or hypomanic behaviors, such as hyper-inflated self-confidence, diminished sleep requirements, extreme talkativeness, and high-risk financial or professional decisions. The second section verifies temporal clustering by assessing whether these symptoms occurred during the same operational timeframe. The final section quantifies the actual functional impairment caused by these behaviors, ranging from negligible disruption to severe professional or personal impairment. By establishing a standardized, tri-factor scoring algorithm, the MDQ helps healthcare professionals and corporate medical advisors make data-driven clinical decisions. A positive screen requires the simultaneous fulfillment of all three criteria: a high symptom count, temporal co-occurrence, and moderate-to-severe functional disruption. Integrating this calculator into executive health assessments, disability case reviews, and employee assistance programs (EAPs) ensures that high-risk cases are routed to specialized psychiatric resources before costly operational disruptions or long-term disability events occur.

Calkulon makes complex calculations simple — built for students and everyday problem-solvers.

1. 1Identify High-Risk Cases for Screening: Deploy the MDQ for employees or patients presenting with recurrent depressive episodes, history of treatment-resistant depression, multiple failed antidepressant trials, or erratic performance patterns. Screening is highly recommended during disability reviews or when evaluating return-to-work readiness for mental health leaves.
2. 2Administer the 13-Item Behavioral Checklist: Have the individual complete the 13 binary (Yes/No) questions. These items assess lifetime occurrences of elevated mood, irritability, hyper-energy, racing thoughts, extreme distractibility, and impulsive financial or professional behaviors. Emphasize that responses must reflect lifetime history, not just current state.
3. 3Verify Temporal Co-occurrence: Evaluate the response to the clustering question: did several of these manic or hypomanic behaviors occur during the same period? This is critical because clinical bipolar diagnoses require symptoms to cluster into distinct, sustained episodes rather than occurring as isolated, disconnected events over several years.
4. 4Quantify Functional Impairment: Assess the degree of disruption these symptoms caused in the individual's life (work, relationships, financial stability). The screening algorithm requires a minimum threshold of 'Moderate' or 'Serious' problem to filter out high-energy, highly productive traits that do not constitute clinical pathology.
5. 5Execute the Tri-Factor Scoring Algorithm: Apply the scoring logic. If the individual answers 'Yes' to 7 or more checklist items, confirms temporal co-occurrence, and reports at least moderate functional impairment, the screen is flagged as positive. Missing any one of these three criteria results in a negative screen.
6. 6Initiate Clinical Referral and Diagnostic Audit: For all positive screens, refer the individual to a licensed psychiatrist or clinical psychologist for a formal diagnostic evaluation. Ensure that no clinical diagnoses or treatment modifications are made based solely on the screening result, as further differential diagnostic testing is required.
7. 7Optimize Case Management & Workplace Accommodations: Use the screening outcomes to guide occupational health strategies. For verified diagnoses following a positive screen, work with HR and medical teams to establish reasonable workplace accommodations, optimize shift schedules, and manage stress triggers to maintain long-term productivity and prevent relapse.

• !Using the MDQ as a Definitive Diagnostic Tool: The MDQ is strictly a screening instrument designed to identify probability, not to formulate a clinical diagnosis. Initiating mood stabilizers or making permanent employment accommodations based solely on a positive MDQ screen, without a comprehensive psychiatric evaluation, is a severe clinical and administrative error.
• !Ignoring Setting-Specific Positive Predictive Value (PPV): In general corporate populations where the baseline prevalence of bipolar disorder is low (around 2-3%), the PPV of the MDQ is approximately 25%. This means 3 out of 4 positive screens will be false positives. Failing to prepare occupational health teams for this high rate of false positives can lead to unnecessary organizational panic and employee distress.
• !Administering the Tool During Acute Manic Crises: The MDQ is designed to capture lifetime history and is most effective when administered during euthymic (stable) or depressive phases. Administering the questionnaire to an employee actively experiencing an acute manic episode is redundant and highly unreliable, as impaired insight and grandiosity during mania frequently lead to severe underreporting or distorted responses.